ClassID:

170257

G01N2333/15 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus

Sub-classes:
Recent Application in this class:
#1
20250052753
2025-02-13

SINGLE PARTICLE ANALYSIS METHOD FOR VIRAL NUCLEIC ACID VECTOR

#2
20240374644
2024-11-14

HERV-K ANTIBODY THERAPEUTICS

#3
20240301040
2024-09-12

ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES

#4
20240280575
2024-08-22

Compositions and Methods for the Detection of Mycoplasma

#5
20240085419
2024-03-14

METHODS AND KITS FOR QUANTIFYING THE REMOVAL OF MOCK VIRUS PARTICLES FROM A PURIFIED SOLUTION

#6
20240060131
2024-02-22

METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE

#7
20230324375
2023-10-12

NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO

#8
20230258643
2023-08-17

ENDOGENOUS RETROVIRUSES FOR THE DETECTION, DIAGNOSIS, AND PROGNOSIS OF CANCER

#9
20230227505
2023-07-20

IDENTIFICATION AND APPLICATION OF ALV-J MHC-B2 RESTRICTIVE EPITOPE PEPTIDE

#10
20230052675
2023-02-16

CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING

#11
20220332799
2022-10-20

HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES

#12
20220042993
2022-02-10

BETARETROVIRUS EPITOPES AND RELATED METHODS OF USE

#13
20220003782
2022-01-06

USE OF LIGANDS DERIVED FROM RECEPTOR-BINDING DOMAIN OF PORCINE ENDOGENOUS RETROVIRUS TYPE B FOR DIAGNOSING SMVT-RELATED DISEASES

#14
20210155906
2021-05-27

STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT

#15
20210139947
2021-05-13

METHOD FOR ASSESSING SUSCEPTIBILITY OF A VIRUS TO TREATMENT BY MEASURING ENZYME ACTIVITY AND A SYSTEM THEREFORE

#16
20200393450
2020-12-17

Detection device for bioluminescent detection of biomarkers from a biological fluid sample using luminescent sensing proteins

#17
20200338067
2020-10-29

CAMPTOTHECIN DERIVATIVES AS ANTI-HIV AGENTS AND METHODS OF IDENTIFYING AGENTS THAT DISRUPT VIF SELF-ASSOCIATION

#18
20200308258
2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

#19
20200200745
2020-06-25

Assays for detecting analytes in samples and kits and compositions related thereto

#20
20200033357
2020-01-30

Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles

#21
20200033342
2020-01-30

Soluble and immunoreactive variants of HTLV capsid antigen P24

#22
20190353656
2019-11-21

Methods and kits for quantifying the removal of mock virus particles from a purified solution

#23
20190345232
2019-11-14

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

#24
20180016558
2018-01-18

STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT

#25
20170334952
2017-11-23

Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression

#26
20170192001
2017-07-06

Methods for evaluating viral clearance from a process solution employing mock viral particles

#27
20170184591
2017-06-29

Soluble and immunoreactive variants of HTLV capsid antigen p24

#28
20170176435
2017-06-22

CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING

#29
20170108494
2017-04-20

Assays for detecting analytes in samples and kits and compositions related thereto

#30
20160143900
2016-05-26

Camptothecin derivatives as anti-HIV agents and methods of identifying agents that disrupt Vif self-association

#31
20160123981
2016-05-05

Method of determining virus removal from a sample containing a target protein using activated carbon

#32
20160090402
2016-03-31

Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides

#33
20150330980
2015-11-19

METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS

#34
20150250864
2015-09-10

ANTI-CANCER VACCINES

#35
20150153355
2015-06-04

Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins

#36
20150125476
2015-05-07

Highly immunogenic peptides derived from the human immunodeficiency virus V2 region

#37
20150072339
2015-03-12

Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles

#38
20150057175
2015-02-26

Method for monitoring HIV specific T cell responses

#39
20140187477
2014-07-03

Inhibitors of viral integrase and methods of use

#40
20120237527
2012-09-20

Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus

#41
20120094896
2012-04-19

Inhibitors of viral integrase and methods of use

#42
20120040864
2012-02-16

Method for Determining the Cbl-b Expression

#43
20110250624
2011-10-13

Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum

#44
20110206695
2011-08-25

ANTIBODIES FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF PROSTATE CANCER

#45
20110151435
2011-06-23

NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO

#46
20110151431
2011-06-23

DETECTION OF XENOTROPIC MURINE LEUKEMIA VIRUS

#47
20110046042
2011-02-24

Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof

#48
20110020352
2011-01-27

ENDOGENOUS RETROVIRUSES UP-REGULATED IN PROSTATE CANCER

#49
20100285509
2010-11-11

Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use

#50
20100285446
2010-11-11

Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry

#51
20100167268
2010-07-01

SEROCONVERSION ASSAYS FOR DETECTING XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS

#52
20100136522
2010-06-03

Endogenous retroviruses up-regulated in prostate cancer

#53
20090180975
2009-07-16

Polynucleotide fragments of an infectious human endogenous retrovirus

#54
20090148454
2009-06-11

Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor

#55
20090130129
2009-05-21

Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use

#56
20090081220
2009-03-26

Method for diagnosing and treatment of breast cancer and pharmaceuticals composition and kit for same

#57
20080008717
2008-01-10

Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus

#58
20070037147
2007-02-15

Endogenous retrovirus polypeptides linked to oncogenic transformation

#59
20060228700
2006-10-12

Novel retrovirus associated with myelodysplastic syndromes and uses thereof

#60
20060204958
2006-09-14

Methods for diagnosing htlv-i-mediated diseases

#61
20060160087
2006-07-20

Monitoring and treatment of amyotrophic lateral sclerosis

#62
20060099583
2006-05-11

Compositions and methods for identifying antiviral agents

#63
20060002957
2006-01-05

Method and device for detecting feline immunodeficiency virus

#64
20050208481
2005-09-22

Diagnostic device using GP40

#65
20050186560
2005-08-25

Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

#66
20050112556
2005-05-26

Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens